Trial intelligence / Profile preview

Tapentadol vs Oxycodone for Pain and Constipation in End-Stage Joint Disease

NCT00784277Phase 3Completed

Sponsor
Johnson & Johnson
Start
Oct 2008
Primary completion
Jul 2009
Modality
Small Molecules
01

Overview

A Phase 3 trial of tapentadol in osteoarthritis (OA), sponsored by Johnson & Johnson. Started Oct 2008; status: completed.

02

Drugs

tapentadol
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT00784277.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00784277.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call